Medical laboratories in the United States by short interest

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

GRAIL leads the 8 medical laboratories in the United States ranked by short interest, at 17.8%, ahead of RadNet (11.3%) and Guardant Health (6.97%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.

Key facts

Companies ranked
8
First
GRAIL17.8%
Median
5.20%
Combined market value
$140B
Countries
1

Market values as of .

United States
All sectors
Medical laboratories
USD
Clear filters
Medical laboratories in the United States by short interest
#CompanyShort interest % ↓Market capPriceToday1 yearPrice, 30 daysCountry
1GRAILGRAL · Health Care17.8%$4.7B$104.84 2.68% up 19% up United States
2RadNetRDNT · Health Care11.3%$5.5B$69.51 3.22% down 9% down United States
3Guardant HealthGH · Health Care6.97%$19.7B$145.59 0.31% up 45% up United States
4BillionToOneBLLN · Health Care6.22%$4.3B$90.20 1.46% down 4% down United States
5NateraNTRA · Health Care4.19%$42B$289.92 0.15% up 28% up United States
6Caris Life SciencesCAI · Health Care4.01%$5.3B$18.54 4.92% down 19% down United States
7Quest DiagnosticsDGX · Health Care3.39%$28.5B$259.09 0.23% down 38% up United States
8Labcorp HoldingsLH · Health Care3.13%$30B$368.88 0.51% down 42% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further.

Questions and answers

Which medical laboratories in the United States rank first by short interest?

GRAIL (17.8%), RadNet (11.3%) and Guardant Health (6.97%) are the top three of the 8 medical laboratories in the United States ranked by short interest as of the 30 Oct 2026 settlement date.

How many medical laboratories in the United States are in this ranking?

8 are ranked by short interest.

What are these medical laboratories in the United States worth together?

The 8 medical laboratories in the United States ranked by short interest have a combined market value of $140B as of the 30 Oct 2026 settlement date.

What does ranking by short interest measure?

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Cite this page

Funkfolio, “Medical laboratories in the United States by short interest”, data as of 19 November 2026. https://funkfolio.com/companies/category/medical-laboratories?country=united-states&by=short-interest

Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.